BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20846263)

  • 41. Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues.
    Arai E; Wakai-Ushijima S; Fujimoto H; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
    Pathobiology; 2011; 78(1):1-9. PubMed ID: 21474971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.
    Ricketts CJ; Hill VK; Linehan WM
    PLoS One; 2014; 9(1):e85621. PubMed ID: 24454902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Level of HOXA5 hypermethylation in acute myeloid leukemia is associated with short-term outcome.
    Kim SY; Hwang SH; Song EJ; Shin HJ; Jung JS; Lee EY
    Korean J Lab Med; 2010 Oct; 30(5):469-73. PubMed ID: 20890077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
    Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
    Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.
    Peters I; Gebauer K; Dubrowinskaja N; Atschekzei F; Kramer MW; Hennenlotter J; Tezval H; Abbas M; Scherer R; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
    Oncol Rep; 2014 Apr; 31(4):1523-30. PubMed ID: 24549248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma.
    Yoo KH; Won KY; Lim SJ; Park YK; Chang SG
    Oncol Lett; 2014 Nov; 8(5):2135-2139. PubMed ID: 25295100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
    Tang W; Cao Y; Ma X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statistical methods for analyzing tissue microarray data.
    Liu X; Minin V; Huang Y; Seligson DB; Horvath S
    J Biopharm Stat; 2004 Aug; 14(3):671-85. PubMed ID: 15468758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
    Chen G; Wang Y; Wang L; Xu W
    Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue.
    Serth J; Peters I; Dubrowinskaja N; Reese C; Albrecht K; Klintschar M; Lafos M; Grote A; Becker A; Hennenlotter J; Stenzl A; Tezval H; Kuczyk MA
    Clin Epigenetics; 2020 Feb; 12(1):33. PubMed ID: 32070431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
    Xu L; He J; Cai Q; Li M; Pu X; Guo Y
    Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism.
    Ponnusamy L; Mahalingaiah PK; Singh KP
    Mol Pharmacol; 2016 Jan; 89(1):27-41. PubMed ID: 26519223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High resolution methylation analysis of the HoxA5 regulatory region in different somatic tissues of laboratory mouse during development.
    Sinha P; Singh K; Sachan M
    Gene Expr Patterns; 2017 Jan; 23-24():59-69. PubMed ID: 28363633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS).
    Serth J; Peters I; Katzendorn O; Dang TN; Moog J; Balli Z; Reese C; Hennenlotter J; Grote A; Lafos M; Tezval H; Kuczyk MA
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An aging and p53 related marker:
    Feiner LK; Tierling S; Holländer S; Glanemann M; Rubie C
    Aging (Albany NY); 2021 Feb; 13(4):4831-4849. PubMed ID: 33547267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship of Methylation within Upper Stream Region of Transcription Starts Site of HOXA5 Gene with Neural Tube Defects.
    Zhang J; Tian T; Yi Q; Wang LL; Ren AG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Dec; 39(6):785-791. PubMed ID: 29338823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accounting for differential variability in detecting differentially methylated regions.
    Wang Y; Teschendorff AE; Widschwendter M; Wang S
    Brief Bioinform; 2019 Jan; 20(1):47-57. PubMed ID: 29912290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development.
    Hershko AY; Kafri T; Fainsod A; Razin A
    Gene; 2003 Jan; 302(1-2):65-72. PubMed ID: 12527197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney cancer: Methylation of obesity-related genes is associated with prognosis.
    Sidaway P
    Nat Rev Urol; 2017 Aug; 14(8):452. PubMed ID: 28607499
    [No Abstract]   [Full Text] [Related]  

  • 60. Analysis of healthy and tumour DNA methylation distributions in kidney-renal-clear-cell-carcinoma using Kullback-Leibler and Jensen-Shannon distance measures.
    Ramakrishnan N; Bose R
    IET Syst Biol; 2017 Jun; 11(3):99-104. PubMed ID: 28518060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.